Results with PCSK9 inhibitor in ODYSSEY OUTCOMES above expectations, mortality benefit included
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Gerald Watts, MD, PhD
Daniel Gaudet, MD, PhD
Pam R. Taub, MD, FACC, FASPC
- MinuteCE®
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
1.00 program creditBørge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
Børge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
